IS7723A - Efnasambönd sem eru gagnleg til meðhöndlunar á sjúkdómum sem svara meðferð sem bælir æðamyndun - Google Patents

Efnasambönd sem eru gagnleg til meðhöndlunar á sjúkdómum sem svara meðferð sem bælir æðamyndun

Info

Publication number
IS7723A
IS7723A IS7723A IS7723A IS7723A IS 7723 A IS7723 A IS 7723A IS 7723 A IS7723 A IS 7723A IS 7723 A IS7723 A IS 7723A IS 7723 A IS7723 A IS 7723A
Authority
IS
Iceland
Prior art keywords
treatment
compounds
angiogenic
useful
diseases
Prior art date
Application number
IS7723A
Other languages
English (en)
Inventor
Lichtenberg Jens
Christophersen Palle
H. Dahl Bjarne
Original Assignee
Neurosearch A/S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neurosearch A/S filed Critical Neurosearch A/S
Publication of IS7723A publication Critical patent/IS7723A/is

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Ophthalmology & Optometry (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Rheumatology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Electrotherapy Devices (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Inorganic Compounds Of Heavy Metals (AREA)
  • Plural Heterocyclic Compounds (AREA)
IS7723A 2002-08-01 2005-03-01 Efnasambönd sem eru gagnleg til meðhöndlunar á sjúkdómum sem svara meðferð sem bælir æðamyndun IS7723A (is)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DKPA200201165 2002-08-01
DKPA200201839 2002-11-28
DKPA200300371 2003-03-11
PCT/DK2003/000518 WO2004012733A2 (en) 2002-08-01 2003-07-31 Compounds useful for the treatment of diseases responsive to antiangiogenetic therapy

Publications (1)

Publication Number Publication Date
IS7723A true IS7723A (is) 2005-03-01

Family

ID=31498946

Family Applications (1)

Application Number Title Priority Date Filing Date
IS7723A IS7723A (is) 2002-08-01 2005-03-01 Efnasambönd sem eru gagnleg til meðhöndlunar á sjúkdómum sem svara meðferð sem bælir æðamyndun

Country Status (17)

Country Link
US (1) US20060058395A1 (is)
EP (1) EP1526851B1 (is)
JP (1) JP2005537336A (is)
KR (1) KR20050026091A (is)
CN (1) CN1671378A (is)
AT (1) ATE372770T1 (is)
AU (1) AU2003260280A1 (is)
BR (1) BR0312929A (is)
CA (1) CA2493253A1 (is)
DE (1) DE60316297T2 (is)
IL (1) IL166040A0 (is)
IS (1) IS7723A (is)
MX (1) MXPA05001235A (is)
NO (1) NO20051074L (is)
NZ (1) NZ537809A (is)
PL (1) PL375318A1 (is)
WO (1) WO2004012733A2 (is)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006527735A (ja) * 2003-06-17 2006-12-07 ノイロサーチ アクティーゼルスカブ ジフェニル尿素誘導体、及びクロライドチャネル遮断剤としてのそれらの使用
US7550499B2 (en) 2004-05-12 2009-06-23 Bristol-Myers Squibb Company Urea antagonists of P2Y1 receptor useful in the treatment of thrombotic conditions
MX2007008434A (es) 2005-01-19 2007-07-25 Squibb Bristol Myers Co Derivados de 2-fenoxi-n-(1,3,4-tiadizol-2il)piridin-3-amina y compuestos relacionados como inhibidores del receptor p2y1 para el tratamiento de trastornos tromboembolicos.
EP1853286A2 (en) * 2005-02-08 2007-11-14 BMZ Diagnosis (2004) Ltd. Composition for treatment of skin disorders
ES2352796T3 (es) 2005-06-27 2011-02-23 Bristol-Myers Squibb Company Antagonistas cíclicos unidos a c del receptor p2y1 útiles en el tratamiento de afecciones trombóticas.
MX2007016501A (es) 2005-06-27 2008-03-06 Squibb Bristol Myers Co Antagonistas heterociclicos n-enlazados del receptor de p2y1, utiles en el tratamiento de condiciones tromboticas.
US7714002B2 (en) 2005-06-27 2010-05-11 Bristol-Myers Squibb Company Carbocycle and heterocycle antagonists of P2Y1 receptor useful in the treatment of thrombotic conditions
EP1896417B1 (en) 2005-06-27 2011-03-23 Bristol-Myers Squibb Company Linear urea mimics antagonists of p2y1 receptor useful in the treatment of thrombotic conditions
US7960569B2 (en) 2006-10-17 2011-06-14 Bristol-Myers Squibb Company Indole antagonists of P2Y1 receptor useful in the treatment of thrombotic conditions
US20110110958A1 (en) * 2007-09-11 2011-05-12 University Of Florida Research Foundation Compositions and methods for the treatment of neoplasia
WO2016001452A1 (en) * 2014-07-04 2016-01-07 Universität Zürich Compounds, in particular for use in the treatment of a disease or condition for which a bromodomain inhibitor is indicated
SI3458052T1 (sl) 2016-05-17 2020-04-30 Scandion Oncology A/S Kombinirano zdravljenje raka
US20210251963A1 (en) * 2018-09-06 2021-08-19 Scandion Oncology A/S Urea derivatives for use in the treatment of subjects with elevated expression and/or activity of srpk1

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996025157A1 (en) * 1995-02-17 1996-08-22 Smithkline Beecham Corporation Il-8 receptor antagonists
IL132107A (en) * 1997-04-22 2004-09-27 Neurosearch As Substituted phenyl derivatives, their preparation and use
JP4607318B2 (ja) * 1997-12-22 2011-01-05 バイエル コーポレイション 対称および非対称置換ジフェニル尿素を用いるｒａｆキナーゼの阻害
CA2342626A1 (en) * 1998-10-22 2000-05-04 Neurosearch A/S Substituted phenyl derivatives, their preparation and use
CO5200760A1 (es) * 1999-06-16 2002-09-27 Smithkline Beecham Corp Antagonistas del receptor de la il-8 ceptor il-8
ATE543497T1 (de) * 2002-07-09 2012-02-15 Bristol Myers Squibb Co Substituierte heterozyklische derivate als mittel gegen diabetes und adipositas und verfahren

Also Published As

Publication number Publication date
CN1671378A (zh) 2005-09-21
EP1526851B1 (en) 2007-09-12
EP1526851A2 (en) 2005-05-04
WO2004012733A9 (en) 2005-03-10
KR20050026091A (ko) 2005-03-14
PL375318A1 (en) 2005-11-28
US20060058395A1 (en) 2006-03-16
DE60316297T2 (de) 2008-06-19
CA2493253A1 (en) 2004-02-12
JP2005537336A (ja) 2005-12-08
NZ537809A (en) 2007-05-31
MXPA05001235A (es) 2005-06-08
IL166040A0 (en) 2006-01-15
NO20051074L (no) 2005-04-29
AU2003260280A1 (en) 2004-02-23
WO2004012733A2 (en) 2004-02-12
WO2004012733A3 (en) 2004-03-18
DE60316297D1 (de) 2007-10-25
BR0312929A (pt) 2005-07-12
ATE372770T1 (de) 2007-09-15

Similar Documents

Publication Publication Date Title
AU2003272285A8 (en) Thienopyrrolyl and furanopyrrolyl compounds and their use as histamine h4 receptor ligands
IS7723A (is) Efnasambönd sem eru gagnleg til meðhöndlunar á sjúkdómum sem svara meðferð sem bælir æðamyndun
TW200509892A (en) Novel aminobenzophenone compounds
MY145077A (en) Pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis
EA200801372A1 (ru) Способы получения замещенных пиримидинов
UA83194C2 (ru) Производные пиримидина и их применение как модуляторов св2
LU91710I9 (is)
WO2004108139A3 (en) Use of fused heterocyclic compounds as scce inhibitors for the treatment of skin conditions or cancer
AU2003220970A1 (en) Diamino-pyrimidines and their use as angiogenesis inhibitors
GB0222495D0 (en) Compounds
TWI319708B (en) Methods and compositions for altering cell fuction
MY141528A (en) Anilinopyrazole derivatives useful for the treatment of diabetes
DE602006016449D1 (is)
NO20054371L (no) Somatostatin-dopamin kimaere analoger
IL165505A0 (en) 2-heteroaryl carboxamides
WO2004069160A3 (en) Chemical compounds
WO2004034985A3 (en) Chemical compounds
WO2006089664A3 (de) Heterocyclylamid-substituierte imidazole
DK1368023T3 (da) Anvendelse af buprenoprphin til behandling af urininkontinens
MXPA05009428A (es) Composiciones y metodos para prevenir y tratar enfermedades relacionadas con endotoxinas.
EP1597234A4 (en) NEW COMPOUNDS
TW200505435A (en) Treatment of ocular disorders
WO2006004774A3 (en) Laulimalide analogues as therapeutic agents
WO2003064394A8 (de) 5-ring heterozyklen zur verwendung als antiviral mittel
UA87984C2 (ru) Повышение уровней масла в растениях